georgia, yemen, afghanistan, cyprus, india, singapore, saudi arabia, maldives, japan, united arab emirates, malaysia, china, south korea, north korea, taiwan, thailand, pakistan, mongolia, brunei, lebanon, indonesia, kyrgyzstan, syria, israel, bhutan, iran, turkey, armenia, qatar, philippines, kazakhstan, iraq, bangladesh, laos, vietnam, timor-leste, kuwait, myanmar, azerbaijan, jordan, nepal, sri lanka, uzbekistan, turkmenistan, macau, bahrain, cambodia, tajikistan
08 Dec 2025 06:01
Medicinova Announces Update And Basic Characteristic Randomized Patients' Of Phase 2/3 Clinical Trial Of MN-166 (Ibudilast) In ALS (COMBAT-ALS Clinical Trial) Presented At The 36Th International Symposium On ALS/MND (menafn)
(MENAFN - GlobeNewsWire - Nasdaq) LA JOLLA, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) -- MediciNova, In...